Preoperative Strength, Assistance in Walking, Rising From a Chair, Climbing Stairs, and Falls (SARC‐F) Score Predicts Adjuvant Chemotherapy Discontinuation in Patients With Colorectal Cancer
Journal of Surgical Oncology · 2025
DOI: 10.1002/jso.70097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Dain Shin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Keimyung University School of Medicine, Daegu, Korea. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Sarcopenia, Muscle Strength, Walking. Die Arbeit nennt 49 Literaturangaben.
Themen: Onkologische Pflege, Sturzprophylaxe
Abstract (Originalsprache)
Background and Objectives Sarcopenia adversely affects clinical outcomes in patients with cancer. Studies indicate that sarcopenia significantly predicts chemotherapy‐induced dose‐limiting toxicities, including early discontinuation, delay, and dose‐reduction, in patients with colorectal, esophageal, digestive, hepatocellular, and renal cancers. The Strength, Assistance for walking, Rising from a chair, Climbing stairs, and Falls (SARC‐F) questionnaire is a simple and effective tool for sarcopenia screening. Adjuvant chemotherapy is the standard treatment for advanced (Stages II/III) colorectal cancer (CRC). Predicting chemotherapy discontinuation could help improve oncologic outcomes. This study aimed to evaluate the correlation between the SARC‐F score and chemotherapy discontinuation.
Methods
This study included 139 patients with CRC who underwent surgery between July 2016 and June 2023, received adjuvant chemotherapy and completed the SARC‐F questionnaire before surgery. The SARC‐F includes five items, each scored from 0 to 2. Patients were divided into two groups based on optimal SARC‐F cutoff value. Treatment discontinuation was analyzed using a logistic regression model.
Results
Patients were categorized into high‐SARC‐F ( n = 18) and low‐SARC‐F ( n = 121) groups. Patients in the high‐SARC‐F group were older ( p < 0.001), had higher rates of hypertension ( p = 0.001) and diabetes mellitus ( p = 0.017), elevated preoperative C‐reactive protein levels ( p < 0.001), and a higher incidence of treatment discontinuation ( p = 0.010). Univariate and multivariate analyses identified a high SARC‐F score as an independent risk factor for chemotherapy discontinuation (odds ratio 3.905, 95% confidence interval 1.100–13.867).
Conclusions
Our findings indicate that the SARC‐F score reflects sarcopenia characteristics and can predict adjuvant chemotherapy discontinuation in patients with CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Keimyung University School of Medicine, Daegu, Korea.
- Department of Statistics, Keimyung University, Daegu, Korea.
- Department of Surgery, School of Medicine, Keimyung University and Dongsan Medical Center, Daegu, Korea.
ORCID-Profile: Sung Uk Bae
Zitieren
APA
Shin, D., Son, N. H., Jeong, W. K., Baek, S. K., & Bae, S. U. (2025). Preoperative Strength, Assistance in Walking, Rising From a Chair, Climbing Stairs, and Falls (SARC‐F) Score Predicts Adjuvant Chemotherapy Discontinuation in Patients With Colorectal Cancer. Journal of Surgical Oncology. https://doi.org/10.1002/jso.70097
Vancouver
Shin D, Son NH, Jeong WK, Baek SK, Bae SU. Preoperative Strength, Assistance in Walking, Rising From a Chair, Climbing Stairs, and Falls (SARC‐F) Score Predicts Adjuvant Chemotherapy Discontinuation in Patients With Colorectal Cancer. Journal of Surgical Oncology. 2025. doi:10.1002/jso.70097
BibTeX
@article{Shin2025,
author = {Shin, Dain and Son, Nak Hoon and Jeong, Woon Kyung and Baek, Seong Kyu and Bae, Sung Uk},
title = {Preoperative Strength, Assistance in Walking, Rising From a Chair, Climbing Stairs, and Falls (SARC‐F) Score Predicts Adjuvant Chemotherapy Discontinuation in Patients With Colorectal Cancer},
journal = {Journal of Surgical Oncology},
year = {2025},
doi = {10.1002/jso.70097}
}
EUVIMED